Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-036513

Director sold 1,666 shares at an average $65.37 ($108,911)

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-26 Sale : show line 1 in the form −894 $64.90 $58,022 134,861 D
2021-05-26 Sale : show line 2 in the form −732 $65.88 $48,221 134,129 D
2021-05-26 Sale : show line 3 in the form −40 $66.72 $2,669 134,089 D
Open-market sales · 1,666 sh · avg $65.37 · $108,911
Loading xslF345X03/doc4.xml…